
Quotient Limited QTNT
Quarterly report 2022-Q4
added 02-09-2023
Quotient Limited Operating Cycle 2011-2026 | QTNT
Annual Operating Cycle Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 432 | 481 | 371 | 610 | 501 | 520 | 208 | 243 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 610 | 208 | 421 |
Quarterly Operating Cycle Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 371 | 67.9 | 103 | - | 325 | 140 | 241 | 449 | 483 | 474 | 477 | 402 | 435 | 402 | 418 | 340 | 366 | 373 | 361 | - | 658 | 532 | 494 | - | 519 | 158 | 215 | - | 317 | 84.3 | 110 | - | 239 | 74.7 | 106 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 658 | 67.9 | 325 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
161 | $ 118.99 | -0.65 % | $ 36.2 B | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 19.95 | -2.97 % | $ 215 M | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 21.86 | 24.42 % | $ 1.16 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 524.79 | 1.21 % | $ 15.1 B | ||
|
NeoGenomics
NEO
|
102 | $ 8.21 | -5.41 % | $ 1.05 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Neogen Corporation
NEOG
|
213 | $ 9.34 | -0.85 % | $ 2.03 B | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 29.04 | -0.17 % | $ 20 B | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 1.4 | -1.41 % | $ 1.86 M | ||
|
Castle Biosciences
CSTL
|
97.9 | $ 24.41 | -0.85 % | $ 678 M | ||
|
Senseonics Holdings
SENS
|
104 | $ 6.78 | -1.74 % | $ 283 M | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | $ 52.61 | 0.07 % | $ 2.67 B | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
Neuronetics
STIM
|
69.1 | $ 1.44 | 3.24 % | $ 95 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 181.44 | 0.49 % | $ 8.99 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
143 | $ 194.37 | -1.9 % | $ 139 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 521.66 | -1.88 % | $ 197 B | ||
|
Interpace Biosciences
IDXG
|
96 | $ 2.06 | -6.51 % | $ 9.11 M | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.7 | 0.07 % | $ 61.9 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 56.77 | -1.48 % | $ 3.4 B | ||
|
Illumina
ILMN
|
198 | $ 132.04 | -0.17 % | $ 21 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 16.2 | 0.19 % | $ 490 M | ||
|
Guardant Health
GH
|
128 | $ 85.68 | 0.97 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
275 | $ 2.85 | -2.73 % | $ 92.5 K | ||
|
Biomerica
BMRA
|
204 | $ 2.2 | 4.27 % | $ 5.05 M | ||
|
Waters Corporation
WAT
|
834 | $ 323.1 | -0.95 % | $ 19.2 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 118.29 | 1.54 % | $ 9.76 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 268.78 | 0.77 % | $ 22.4 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 5.15 | -0.87 % | $ 477 M | ||
|
Lantheus Holdings
LNTH
|
121 | $ 83.57 | -0.44 % | $ 5.64 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 193.81 | 1.25 % | $ 21.5 B |